Impact of treatment delays on outcomes of primary percutaneous coronary intervention for acute myocardial infarction: Analysis from the CADILLAC trial

The impact of treatment delays on outcomes after primary percutaneous coronary intervention for acute myocardial infarction is controversial. The CADILLAC trial randomized 2082 patients with acute myocardial infarction to stenting versus percutaneous transluminal coronary angioplasty, each with or w...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American heart journal 2006-06, Vol.151 (6), p.1231-1238
Hauptverfasser:	Brodie, Bruce R., Stone, Gregg W., Cox, David A., Stuckey, Thomas D., Turco, Mark, Tcheng, James E., Berger, Peter, Mehran, Roxana, McLaughlin, Michael, Costantini, Costantino, Lansky, Alexandra J., Grines, Cindy L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Angioplasty, Balloon, Coronary Biological and medical sciences Cardiology. Vascular system Clinical outcomes Coronary heart disease Diabetes Female Heart Heart attacks Heart surgery Humans Hypertension Male Medical imaging Medical sciences Mortality Myocardial Infarction - mortality Myocardial Infarction - surgery Myocarditis. Cardiomyopathies Stents Survival Rate Time Factors Treatment Outcome Veins & arteries
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The impact of treatment delays on outcomes after primary percutaneous coronary intervention for acute myocardial infarction is controversial. The CADILLAC trial randomized 2082 patients with acute myocardial infarction to stenting versus percutaneous transluminal coronary angioplasty, each with or without abciximab. Earlier reperfusion (6 hours) was associated with lower 1-year mortality (2.6% vs 4.3% vs 4.8%, P = .046 for
ISSN:	0002-8703 1097-6744
DOI:	10.1016/j.ahj.2005.07.016